Stock Screener App

무료 -

9.49

0.21% +0.02

Benitec Biopharma Inc (BNTC)

개요 뉴스 가격 이력 Financials 토론 예측 주식 분할

Benitec Biopharma Inc 주식(BNTC)의 최신 뉴스

Trend Tracker for (BNTC) - Stock Traders Daily

Stock Traders Daily

Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update - Markets Insider

Markets Insider

Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update

GlobeNewswire Inc.

(BNTC) Technical Pivots with Risk Controls - Stock Traders Daily

Stock Traders Daily

Benitec Biopharma to Participate in the Citizens JMP Life Science Conference - GlobeNewswire

Benitec Biopharma to Participate in the Citizens JMP Life Science Conference - GlobeNewswire

Benitec Biopharma's $40 Million Equity Financing Deal - TipRanks.com - TipRanks

Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study

GlobeNewswire Inc.

Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

GlobeNewswire Inc.

Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b ... - GlobeNewswire

Wall Street Breakfast: The Week Ahead

Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular ... - GlobeNewswire

Here's Why Benitec Biopharma Inc.'s (NASDAQ:BNTC) CEO Compensation Is The Least Of Shareholders Concerns - Yahoo Finance

Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire Inc.

Citadel Advisors LLC Acquires New Stake in Benitec Biopharma Inc - Yahoo Finance

JANUS HENDERSON GROUP PLC Acquires New Stake in Benitec Biopharma Inc - Yahoo Finance

Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering - Yahoo Finance

Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering - Yahoo Finance

Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023 - Yahoo Finance

Benitec's BB-301 cleared to enter clinic in US for oculopharyngeal muscular dystrophy-related dysphagia - BioWorld Online

BioWorld Online

Global RNAi Therapeutics Market 2023 to 2027: Featuring Sanofi, Alnylam Pharmaceuticals, Arrowhead ... - Yahoo Finance

7 Cheap Robinhood Stocks Under $1 To Watch Trading For Pennies - Penny Stocks

Benitec Biopharma begins OPMD subject enrolment - Clinical Trials Arena

Clinical Trials Arena

Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program - GlobeNewswire

Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022 - PR Newswire

Benitec Biopharma Announces Successful Results from the Interim Analysis of the BB-301 Pilot Dosing Study - PR Newswire

Benitec Biopharma Announces Closing of $11.5 Million Public Offering and Full Exercise of Underwriter's Option to ... - PR Newswire

Benitec's BB-301 for Treating OPMD Is Granted FDA Orphan Drug Status - Muscular Dystrophy News

Muscular Dystrophy News

BNTC Stock Price and Chart — NASDAQ:BNTC - TradingView

Dr Graham’s patented elixir: Gene silencing, miracle cures and Balmain’s biggest biotech company - The Monthly

Acquisition of Tacere Therapeutics and Phase I/II Ready HCV Program - Technology Networks

Technology Networks

$77.56

0.77%

$149.40

1.20%

$29.98

1.11%

$172.85

1.06%

$365.81

2.87%

$90.61

2.55%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기